COVID-19 mRNA vaccine, but not a viral vector-based vaccine, promotes neutralizing anti-type I interferon autoantibody production in a small group of healthy individuals.

Xu, Wanli; Wen, Xiaoting; Cong, Xiaomei; Jiang, Wei

Xu, Wanli; Wen, Xiaoting; Cong, Xiaomei; Jiang, Wei.

Afiliação

Xu W; University of Connecticut, School of Nursing, Storrs, Connecticut, USA.
Wen X; Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Cong X; Yale University, School of Nursing, West Haven, Connecticut, USA.
Jiang W; Ralph H. Johnson VA Medical Center, Charleston, South Carolina, USA.

J Med Virol ; 95(10): e29137, 2023 10.

Article em En | MEDLINE | ID: mdl-37792386

Assuntos

COVID-19; Interferon Tipo I; Vacinas Virais; Humanos; Vacinas contra COVID-19; Autoanticorpos; Leucócitos Mononucleares; COVID-19/prevenção & controle; SARS-CoV-2; Imunoglobulina G

Palavras-chave

COVID-19; COVID-19 mRNA vaccine; a viral vector-based COVID-19 vaccine; autoantibodies against type I interferons

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Vacinas Virais / Interferon Tipo I / COVID-19 Limite: Humans Idioma: En Revista: J Med Virol Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google